Challenge
Health care and the price of drugs has always been a top issue among American voters. The AAM brand was stagnant and failing to engage with its audience. This led to a lack of support for critical legislation related to generic and biosimilar medications.
Solution
To sway lawmakers on legislation affecting patient access to generics and biosimilar medicines, we knew AAM needed a brand refresh and engagement with the community of generic and biosimilar medicine advocates in the critical early summer months and at the end of the fiscal year when relevant legislation is considered.
Model B launched AAM’s first-ever digital grassroots campaigns with data-driven marketing strategies to revitalize its advocacy efforts and spark consumer engagement with lawmakers. This included…
Digital Grassroots Campaigns
Launched targeted digital campaigns in key states to drive lead generation, social engagement, and advocacy actions.
Compelling Visuals
Developed an eye-catching infographic, “Skyrocketing Drug Prices Are a Threat to Everyone,” featuring a unique pill-shaped rocket ship design.
Clear Messaging
Focused on the simple message that generics and biosimilars are crucial for lowering prescription costs and that patient support is essential.
600
New Advocates
>105%
Increase in social engagement
2018 ASAE Gold Circle Award for the best site/app
2018 ASAE Merit Award for the rebranding campaign
2018 Gold Hermes Award for Facebook Engagement
